CareDx(CDNA)

Search documents
CareDx(CDNA) - 2022 Q4 - Earnings Call Presentation
2023-02-28 03:36
| --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------|-------|-----------|-------|-----------------------------|-------|-------| | | | | | | | | | Focused on improving care across the entire transplant patient journey The Transplant Company Q4 and FY 2022 | ™ | | | | | | | | | Leslie M, | | Kidney Transplant Recipient | | | | Earnings Presentation | | | | | | | Safe Harbor Statement 2023 Focus On The Three ...
CareDx(CDNA) - 2022 Q4 - Annual Report
2023-02-26 16:00
Environmental Matters Table of Contents company☐ company☐ Portions of the registrant's Proxy Statement relating to the 2023 Annual Meeting of Stockholders, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Proxy Statement, or an amendment to this Annual Report on Form 10-K, will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant's fiscal year ended December 31, 2022. TABLE OF CONTENTS PART III 127 Item 10. D ...
CareDx(CDNA) - 2022 Q3 - Earnings Call Transcript
2022-11-04 02:52
CareDx, Inc (NASDAQ:CDNA) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Ian Cooney - VP, IR Reg Seeto - CEO Abhishek Jain - Interim CFO Conference Call Participants Brandon Couillard - Jefferies Operator Good day, ladies and gentlemen, and welcome to the CareDx, Incorporated Third Quarter 2022 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Ian Cooney. Please go ahead. Ian Cooney Good afternoon, and ...
CareDx(CDNA) - 2022 Q3 - Earnings Call Presentation
2022-11-03 22:13
| --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------|-------|-----------|-------|-----------------------------|-------|-------| | | | | | | | | | Focused on improving care across the entire transplant patient journey The Transplant Company Q3 2022 | ™ | | | | | | | | | Leslie M, | | Kidney Transplant Recipient | | | | Earnings Presentation | | | | | | | Safe Harbor Statement These slides and the accompanying ora ...
CareDx(CDNA) - 2022 Q3 - Quarterly Report
2022-11-02 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-365 ...
CareDx(CDNA) - 2022 Q2 - Earnings Call Transcript
2022-08-07 15:34
CareDx, Inc. (NASDAQ:CDNA) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Ian Cooney - VP, IR Reg Seeto - CEO Abhishek Jain - Interim CFO Conference Call Participants Andrew Cooper - Raymond James Alex Nowak - Craig-Hallum Capital Group Brandon Couillard - Jefferies Jacob Johnson - Stephens Yi Chen - H.C. Wainwright E.V. Koslosky - Goldman Sachs Operator Good day, and welcome to the CareDx, Inc. Second Quarter 2022 Earnings Call. Today’s conference is being recorded. At this ...
CareDx(CDNA) - 2022 Q2 - Quarterly Report
2022-08-03 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 __ ...
CareDx(CDNA) - 2022 Q1 - Earnings Call Transcript
2022-05-06 02:50
CareDx, Inc (NASDAQ:CDNA) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Ian Cooney - VP of IR Reg Seeto - CEO Ankur Dhingra - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Andrew Cooper - Raymond James Mason Carrico - Stephens Inc. Operator Good day, and welcome to the CareDx First Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn t ...
CareDx(CDNA) - 2022 Q1 - Quarterly Report
2022-05-04 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 _ ...
CareDx(CDNA) - 2021 Q4 - Earnings Call Transcript
2022-02-25 01:46
CareDx, Inc (NASDAQ:CDNA) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Ian Cooney - Vice President of Investor Relations Reg Seeto - President & Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Dipesh Patel - H.C. Wainwright Andrew Cooper - Raymond James Operator Thank you for standing by. This is the conference operator. Welcome to the CareDx, Inc. Fourth Quarter 2021 Earnings Conferenc ...